ClinConnect ClinConnect Logo
Search / Trial NCT06835335

Opioid Prescribing in the Emergency Department for Sickle Cell Disease

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Feb 14, 2025

Trial Information

Current as of July 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how emergency doctors prescribe pain relief, specifically opioids, to patients with sickle cell disease who come to the emergency room with severe abdominal pain. It aims to understand if there are any differences in how doctors treat these patients, especially considering issues like discrimination and racial bias in healthcare. The study will involve presenting a scenario to emergency doctors and asking what pain medications they would choose for a patient in this situation.

To participate in this study, you need to be an emergency physician working in Europe. Unfortunately, if you're outside of Europe, you won’t be eligible to take part. While this study is not yet recruiting participants, it will provide important insights into pain management for sickle cell disease and how it might be affected by a doctor's background or beliefs. This research could help improve care for patients by highlighting any biases that may exist in treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being a emergency physician
  • Exclusion Criteria:
  • Working outside of Europe.

About Centre Hospitalier Universitaire De Nīmes

The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.

Locations

Nîmes, Occitanie, France

Manchester, , United Kingdom

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported